Douglas L. Kieta
Known title: DirectorCIK: 0001359803
Associated companies
Transaction History
| ALTO | ▲ Buy | Grant | 49,166 | $0 | 6/20/2024 | View on chart |
| ALTO | ▲ Buy | Grant | 73,750 | $0 | 6/22/2023 | View on chart |
| ALTO | ▲ Buy | Grant | 20,109 | $0 | 6/23/2022 | View on chart |
| ALTO | ▲ Buy | Grant | 49,166 | $0 | 6/20/2024 | View on chart |
| ALTO | ▲ Buy | Grant | 73,750 | $0 | 6/22/2023 | View on chart |
| ALTO | ▲ Buy | Grant | 20,109 | $0 | 6/23/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
StoneX initiates coverage on Alto Ingredients with $7 target
StoneX has begun tracking Alto Ingredients, assigning a Buy rating and a price target of $7. This new analyst view places the stock within the current 52-week range of $0.99 to $6.11. The move adds to the existing analyst consensus, which currently averages a target of $9.00 based on two estimates.
StoneX initiates coverage on Alto Ingredients with $7 target. StoneX has begun tracking Alto Ingredients, assigning a Buy rating and a price target of $7. This new analyst view places the stock within the current 52-week range of $0.99 to $6.11. The move adds to the existing analyst consensus, which currently averages a target of $9.00 based on two estimates.